Brief: Destiny Pharma Identifies New Life Cycle Management Targets For XF-73 Nasal
06/07/2023 07:32
July 6 (Reuters) - Destiny Pharma PLC DEST.L :
* DESTINY PHARMA PLC - CONFIRMS PROPOSED PHASE 3 DEVELOPMENT
PATHWAY AND IDENTIFIES NEW LIFE CYCLE MANAGEMENT TARGETS FOR
XF-73 NASAL
Source text for Eikon: ID:nRSF1054Fa
Further company coverage: DEST.L
((Reuters.Briefs@thomsonreuters.com;))